Literature DB >> 25910834

Safety assessment of [3S, 3'S]-astaxanthin--Subchronic toxicity study in rats.

R Buesen1, S Schulte2, V Strauss1, S Treumann1, M Becker1, S Gröters1, S Carvalho3, B van Ravenzwaay4.   

Abstract

Astaxanthin, a naturally occurring xanthophyll, is commercially used as a coloring agent in salmon feed, but also marketed as a dietary supplement. The objective of this study was to investigate the subchronic toxicity of synthetic [3S, 3'S]-Astaxanthin in rats. A powder formulation containing approximately 20% [3S, 3'S]-Astaxanthin was administered via the diet to groups of 10 male and 10 female Wistar rats at concentrations of 5000, 15,000 and 50,000 ppm for a period of 13 weeks. A formulation of comparable composition but without [3S, 3'S]-Astaxanthin served as a placebo control. There were no effects observed on survival, clinical examinations, clinical pathology, estrous cycle as well as on sperm parameters. At terminal necropsy, a macroscopically visible brown-blue discoloration of the gastrointestinal contents was noted which was considered to be secondary to the violet-brown color of the test material. No other significant or dose-related abnormalities were found in the tissues collected at termination. Our observations support that ingestion of [3S, 3'S]-Astaxanthin of up to 700-920 mg/kg bw/day in rats in a gelatin/carbohydrate formulation is without adverse effects.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Astaxanthin; Rat; Subchronic toxicity

Mesh:

Substances:

Year:  2015        PMID: 25910834     DOI: 10.1016/j.fct.2015.04.017

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  7 in total

Review 1.  Trends in use, pharmacology, and clinical applications of emerging herbal nutraceuticals.

Authors:  Elizabeth M Williamson; Xinmin Liu; Angelo A Izzo
Journal:  Br J Pharmacol       Date:  2020-02-06       Impact factor: 8.739

2.  Simultaneous Inhibitory Effects of All-Trans Astaxanthin on Acetylcholinesterase and Oxidative Stress.

Authors:  Xin Wang; Tao Zhang; Xiaochen Chen; Yating Xu; Zhipeng Li; Yuanfan Yang; Xiping Du; Zedong Jiang; Hui Ni
Journal:  Mar Drugs       Date:  2022-03-31       Impact factor: 6.085

3.  Astaxanthin increases progesterone production in cultured bovine luteal cells.

Authors:  Hachiro Kamada; Satoshi Akagi; Shinya Watanabe
Journal:  J Vet Med Sci       Date:  2017-04-23       Impact factor: 1.267

Review 4.  Astaxanthin for the Food Industry.

Authors:  Barbara Stachowiak; Piotr Szulc
Journal:  Molecules       Date:  2021-05-02       Impact factor: 4.411

Review 5.  Bioaccessibility of Marine Carotenoids.

Authors:  Isabel Viera; Antonio Pérez-Gálvez; María Roca
Journal:  Mar Drugs       Date:  2018-10-22       Impact factor: 5.118

6.  Inhibitory Effect of Astaxanthin on Testosterone-Induced Benign Prostatic Hyperplasia in Rats.

Authors:  Liping Wang; Yiwen Hou; Rong Wang; Qi Pan; Debao Li; Han Yan; Zuyue Sun
Journal:  Mar Drugs       Date:  2021-11-23       Impact factor: 5.118

Review 7.  Astaxanthin from Crustaceans and Their Byproducts: A Bioactive Metabolite Candidate for Therapeutic Application.

Authors:  Vida Šimat; Nikheel Bhojraj Rathod; Martina Čagalj; Imen Hamed; Ivana Generalić Mekinić
Journal:  Mar Drugs       Date:  2022-03-12       Impact factor: 5.118

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.